Severe and Fatal Multilobar Nonclassic Radiation Pneumonitis following Stereotactic Body Radiation Therapy (SBRT) for Treatment of Inoperable Non-Small-Cell Lung Cancer: A Report of Two Cases and Possible Enhancement by Concurrent Amiodarone

Stereotactic body radiation therapy (SBRT) is considered the standard of care for treatment of inoperable early stage non-small cell carcinoma of the lung. SBRT delivers a very high dose of ionizing radiation to a relatively small region encompassing the tumor and spares a significant portion of the...

Full description

Saved in:
Bibliographic Details
Main Authors: Anastasios Georgiou, Adam Farmer
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Pulmonology
Online Access:http://dx.doi.org/10.1155/2019/8754951
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563346060083200
author Anastasios Georgiou
Adam Farmer
author_facet Anastasios Georgiou
Adam Farmer
author_sort Anastasios Georgiou
collection DOAJ
description Stereotactic body radiation therapy (SBRT) is considered the standard of care for treatment of inoperable early stage non-small cell carcinoma of the lung. SBRT delivers a very high dose of ionizing radiation to a relatively small region encompassing the tumor and spares a significant portion of the remaining lung from high doses. However, the conformal high dose comes at the expense of treating a larger volume of normal lung to lower doses. In general, this has been deemed to be acceptable with an overall lower risk of radiation pneumonitis. However, in the face of predisposing factors, the higher doses delivered by this technique may lead to an increase in radiation pneumonitis. We report on two patients being treated with SBRT in which severe radiation pneumonitis developed in spite of our radiation dosimetry being significantly below the acceptable limit for lung toxicity. Both patients developed a “fulminant” form of radiation pneumonitis with radiographic abnormalities well beyond the treated volume. In one patient, the disease proved fatal. Both patients were on amiodarone at the time SBRT was administered. Given the rarity of fulminant radiation pneumonitis, especially with the relatively small fields treated by SBRT, we suspect that amiodarone enhanced the pulmonary toxicity.
format Article
id doaj-art-27f8acba8c6e4f5ba5ffb48d62af877c
institution Kabale University
issn 2090-6846
2090-6854
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Pulmonology
spelling doaj-art-27f8acba8c6e4f5ba5ffb48d62af877c2025-02-03T01:20:23ZengWileyCase Reports in Pulmonology2090-68462090-68542019-01-01201910.1155/2019/87549518754951Severe and Fatal Multilobar Nonclassic Radiation Pneumonitis following Stereotactic Body Radiation Therapy (SBRT) for Treatment of Inoperable Non-Small-Cell Lung Cancer: A Report of Two Cases and Possible Enhancement by Concurrent AmiodaroneAnastasios Georgiou0Adam Farmer1Radiation Oncology, Carl Kirkland Cancer Center, 620 W. Forest Ave, Jackson, TN 38301, USACarl Kirkland Cancer Center, 620 W. Forest Ave., Jackson, TN 38301, USAStereotactic body radiation therapy (SBRT) is considered the standard of care for treatment of inoperable early stage non-small cell carcinoma of the lung. SBRT delivers a very high dose of ionizing radiation to a relatively small region encompassing the tumor and spares a significant portion of the remaining lung from high doses. However, the conformal high dose comes at the expense of treating a larger volume of normal lung to lower doses. In general, this has been deemed to be acceptable with an overall lower risk of radiation pneumonitis. However, in the face of predisposing factors, the higher doses delivered by this technique may lead to an increase in radiation pneumonitis. We report on two patients being treated with SBRT in which severe radiation pneumonitis developed in spite of our radiation dosimetry being significantly below the acceptable limit for lung toxicity. Both patients developed a “fulminant” form of radiation pneumonitis with radiographic abnormalities well beyond the treated volume. In one patient, the disease proved fatal. Both patients were on amiodarone at the time SBRT was administered. Given the rarity of fulminant radiation pneumonitis, especially with the relatively small fields treated by SBRT, we suspect that amiodarone enhanced the pulmonary toxicity.http://dx.doi.org/10.1155/2019/8754951
spellingShingle Anastasios Georgiou
Adam Farmer
Severe and Fatal Multilobar Nonclassic Radiation Pneumonitis following Stereotactic Body Radiation Therapy (SBRT) for Treatment of Inoperable Non-Small-Cell Lung Cancer: A Report of Two Cases and Possible Enhancement by Concurrent Amiodarone
Case Reports in Pulmonology
title Severe and Fatal Multilobar Nonclassic Radiation Pneumonitis following Stereotactic Body Radiation Therapy (SBRT) for Treatment of Inoperable Non-Small-Cell Lung Cancer: A Report of Two Cases and Possible Enhancement by Concurrent Amiodarone
title_full Severe and Fatal Multilobar Nonclassic Radiation Pneumonitis following Stereotactic Body Radiation Therapy (SBRT) for Treatment of Inoperable Non-Small-Cell Lung Cancer: A Report of Two Cases and Possible Enhancement by Concurrent Amiodarone
title_fullStr Severe and Fatal Multilobar Nonclassic Radiation Pneumonitis following Stereotactic Body Radiation Therapy (SBRT) for Treatment of Inoperable Non-Small-Cell Lung Cancer: A Report of Two Cases and Possible Enhancement by Concurrent Amiodarone
title_full_unstemmed Severe and Fatal Multilobar Nonclassic Radiation Pneumonitis following Stereotactic Body Radiation Therapy (SBRT) for Treatment of Inoperable Non-Small-Cell Lung Cancer: A Report of Two Cases and Possible Enhancement by Concurrent Amiodarone
title_short Severe and Fatal Multilobar Nonclassic Radiation Pneumonitis following Stereotactic Body Radiation Therapy (SBRT) for Treatment of Inoperable Non-Small-Cell Lung Cancer: A Report of Two Cases and Possible Enhancement by Concurrent Amiodarone
title_sort severe and fatal multilobar nonclassic radiation pneumonitis following stereotactic body radiation therapy sbrt for treatment of inoperable non small cell lung cancer a report of two cases and possible enhancement by concurrent amiodarone
url http://dx.doi.org/10.1155/2019/8754951
work_keys_str_mv AT anastasiosgeorgiou severeandfatalmultilobarnonclassicradiationpneumonitisfollowingstereotacticbodyradiationtherapysbrtfortreatmentofinoperablenonsmallcelllungcancerareportoftwocasesandpossibleenhancementbyconcurrentamiodarone
AT adamfarmer severeandfatalmultilobarnonclassicradiationpneumonitisfollowingstereotacticbodyradiationtherapysbrtfortreatmentofinoperablenonsmallcelllungcancerareportoftwocasesandpossibleenhancementbyconcurrentamiodarone